lysyl-aspartyl-glutamyl-leucine has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, M; Delie, F; Petignat, P; Ribaux, P | 1 |
Abad, JL; Bernad, A; Gómez-Moutón, C; González, MA; Lacalle, RA; Mañes, S; Martínez-A, C; Mira, E | 1 |
2 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Invasiveness, Neoplasm
Article | Year |
---|---|
Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer?
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Molecular Targeted Therapy; Nanoparticles; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Protein Sorting Signals | 2012 |
A role for chemokine receptor transactivation in growth factor signaling.
Topics: Breast Neoplasms; Cell Polarity; Chemokine CCL5; Chemotaxis; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Insulin-Like Growth Factor I; Ligands; Mutation; Neoplasm Invasiveness; Oligopeptides; Phosphorylation; Protein Sorting Signals; Receptors, CCR5; RNA, Messenger; Signal Transduction; Transcriptional Activation; Tumor Cells, Cultured | 2001 |